{"pmid":32301553,"title":"Lack of dyspnea in Covid-19 patients; another neurological conundrum?","text":["Lack of dyspnea in Covid-19 patients; another neurological conundrum?","One relevant feature of the Covid-19 disease is the absence of dyspnea, described as 'shortness of breath' or 'an unpleasant urge to breathe'. The lack of dyspnea is observed even in the most severe cases, in which subjects present tachypnea and tachycardia. In the Wuhan cohort, 62.4% of severe cases and 46.3% of those who ended up intubated, ventilated or dead did not present dyspnea[1,2].","Eur J Neurol","Bertran Recasens, Bernat","Martinez-Llorens, Juana Maria","Rodriguez-Sevilla, Juan Jose","Rubio, Miguel Angel","32301553"],"abstract":["One relevant feature of the Covid-19 disease is the absence of dyspnea, described as 'shortness of breath' or 'an unpleasant urge to breathe'. The lack of dyspnea is observed even in the most severe cases, in which subjects present tachypnea and tachycardia. In the Wuhan cohort, 62.4% of severe cases and 46.3% of those who ended up intubated, ventilated or dead did not present dyspnea[1,2]."],"journal":"Eur J Neurol","authors":["Bertran Recasens, Bernat","Martinez-Llorens, Juana Maria","Rodriguez-Sevilla, Juan Jose","Rubio, Miguel Angel"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32301553","week":"202016|Apr 13 - Apr 19","doi":"10.1111/ene.14265","source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664357978641268737,"score":8.233237,"similar":[{"pmid":32240670,"pmcid":"PMC7118526","title":"Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up.","text":["Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up.","OBJECTIVE: To investigate the characteristics and prognostic factors in the elderly patients with COVID-19. METHODS: Consecutive cases over 60 years old with COVID-19 in Renmin Hospital of Wuhan University from Jan 1 to Feb 6, 2020 were included. The primary outcomes were death and survival till March 5. Data of demographics, clinical features, comorbidities, laboratory tests and complications were collected and compared for different outcomes. Cox regression was performed for prognostic factors. RESULTS: 339 patients with COVID-19 (aged 71+/-8 years,173 females (51%)) were enrolled, including 80 (23.6%) critical, 159 severe (46.9%) and 100 moderate (29.5%) cases. Common comorbidities were hypertension (40.8%), diabetes (16.0%) and cardiovascular disease (15.7%). Common symptoms included fever (92.0%), cough (53.0%), dyspnea (40.8%) and fatigue (39.9%). Lymphocytopenia was a common laboratory finding (63.2%). Common complications included bacterial infection (42.8%), liver enzyme abnormalities (28.7%) and acute respiratory distress syndrome (21.0%). Till Mar 5, 2020, 91 cases were discharged (26.8%), 183 cases stayed in hospital (54.0%) and 65 cases (19.2%) were dead. Shorter length of stay was found for the dead compared with the survivors (5 (3-8) vs. 28 (26-29), P < 0.001). Symptoms of dyspnea (HR 2.35, P=0.001), comorbidities including cardiovascular disease (HR 1.86, P=0.031) and chronic obstructive pulmonary disease (HR 2.24, P=0.023), and acute respiratory distress syndrome (HR 29.33, P < 0.001) were strong predictors of death. And a high level of lymphocytes was predictive of better outcome (OR=0.10, P < 0.001). CONCLUSIONS: High proportion of severe to critical cases and high fatality rate were observed in the elderly COVID-19 patients. Rapid disease progress was noted in the dead with a median survival time of 5 days after admission. Dyspnea, lymphocytopenia, comorbidities including cardiovascular disease and chronic obstructive pulmonary disease, and acute respiratory distress syndrome were predictive of poor outcome. Close monitoring and timely treatment should be performed for the elderly patients at high risk.","J Infect","Wang, Lang","He, Wenbo","Yu, Xiaomei","Hu, Dalong","Bao, Mingwei","Liu, Huafen","Zhou, Jiali","Jiang, Hong","32240670"],"abstract":["OBJECTIVE: To investigate the characteristics and prognostic factors in the elderly patients with COVID-19. METHODS: Consecutive cases over 60 years old with COVID-19 in Renmin Hospital of Wuhan University from Jan 1 to Feb 6, 2020 were included. The primary outcomes were death and survival till March 5. Data of demographics, clinical features, comorbidities, laboratory tests and complications were collected and compared for different outcomes. Cox regression was performed for prognostic factors. RESULTS: 339 patients with COVID-19 (aged 71+/-8 years,173 females (51%)) were enrolled, including 80 (23.6%) critical, 159 severe (46.9%) and 100 moderate (29.5%) cases. Common comorbidities were hypertension (40.8%), diabetes (16.0%) and cardiovascular disease (15.7%). Common symptoms included fever (92.0%), cough (53.0%), dyspnea (40.8%) and fatigue (39.9%). Lymphocytopenia was a common laboratory finding (63.2%). Common complications included bacterial infection (42.8%), liver enzyme abnormalities (28.7%) and acute respiratory distress syndrome (21.0%). Till Mar 5, 2020, 91 cases were discharged (26.8%), 183 cases stayed in hospital (54.0%) and 65 cases (19.2%) were dead. Shorter length of stay was found for the dead compared with the survivors (5 (3-8) vs. 28 (26-29), P < 0.001). Symptoms of dyspnea (HR 2.35, P=0.001), comorbidities including cardiovascular disease (HR 1.86, P=0.031) and chronic obstructive pulmonary disease (HR 2.24, P=0.023), and acute respiratory distress syndrome (HR 29.33, P < 0.001) were strong predictors of death. And a high level of lymphocytes was predictive of better outcome (OR=0.10, P < 0.001). CONCLUSIONS: High proportion of severe to critical cases and high fatality rate were observed in the elderly COVID-19 patients. Rapid disease progress was noted in the dead with a median survival time of 5 days after admission. Dyspnea, lymphocytopenia, comorbidities including cardiovascular disease and chronic obstructive pulmonary disease, and acute respiratory distress syndrome were predictive of poor outcome. Close monitoring and timely treatment should be performed for the elderly patients at high risk."],"journal":"J Infect","authors":["Wang, Lang","He, Wenbo","Yu, Xiaomei","Hu, Dalong","Bao, Mingwei","Liu, Huafen","Zhou, Jiali","Jiang, Hong"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240670","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.jinf.2020.03.019","keywords":["Coronavirus Infections","Pneumonia","Prognosis","SARS-CoV-2"],"source":"PubMed","locations":["Lymphocytopenia"],"topics":["Diagnosis"],"weight":1,"_version_":1663352135654309888,"score":149.54175},{"pmid":32242738,"title":"Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study.","text":["Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study.","BACKGROUND: The global death toll from COVID-19 virus exceeds 21000. The risk factors for death were attributed to advanced age and co-morbidities, but haven't been accurately defined. OBJECTIVES: To report the clinical features of 85 fatal cases with COVID-19 in two hospitals in Wuhan. METHOD: Medical records of 85 fatal cases of COVID-19 between January 9 and February 15, 2020 were collected. Information recorded included medical history, exposure history, comorbidities, symptoms, laboratory findings, CT scans and clinical management. MEASUREMENTS AND MAIN RESULTS: The median age of the patients was 65.8 years and 72.9% were male. Common symptoms were fever (78 [91.8%]), shortness of breath (50 [58.8%]), fatigue (50 [58.8%]), dyspnea (60 [70.6%]). Hypertension, diabetes and coronary heart disease were the most common comorbidities. Notably, 81.2% patients had very low eosinophil counts at admission. Complications included respiratory failure (80 [94.1%]), shock (69 [81.2%]), ARDS (63 [74.1%]), arrhythmia (51 [60%]), etc. Most patients received antibiotic (77 [90.6%]), antiviral (78 [91.8%]) and glucocorticoids (65 [76.5%]) treatments. 38 patients [44.7%] and 33 [38.8%] received intravenous immunoglobulin and interferon alpha2b respectively. CONCLUSIONS: In this depictive study of 85 fatal cases of COVID-19, most cases were male aged over 50 years old with noncommunicable chronic diseases. The majority of the patients died of multiple organ failure. Early onset of shortness of breath may be used as an observational symptom for COVID-19 exacerbations. Eosinophilopenia may indicate a poor prognosis. The combination of anti-microbial drugs did not offer considerable benefit to the outcome of this group of patients. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).","Am J Respir Crit Care Med","Du, Yingzhen","Tu, Lei","Zhu, Pingjun","Mu, Mi","Wang, Runsheng","Yang, Pengcheng","Wang, Xi","Hu, Chao","Ping, Rongyu","Hu, Peng","Li, Tianzhi","Cao, Feng","Chang, Christopher","Hu, Qinyong","Jin, Yang","Xu, Guogang","32242738"],"abstract":["BACKGROUND: The global death toll from COVID-19 virus exceeds 21000. The risk factors for death were attributed to advanced age and co-morbidities, but haven't been accurately defined. OBJECTIVES: To report the clinical features of 85 fatal cases with COVID-19 in two hospitals in Wuhan. METHOD: Medical records of 85 fatal cases of COVID-19 between January 9 and February 15, 2020 were collected. Information recorded included medical history, exposure history, comorbidities, symptoms, laboratory findings, CT scans and clinical management. MEASUREMENTS AND MAIN RESULTS: The median age of the patients was 65.8 years and 72.9% were male. Common symptoms were fever (78 [91.8%]), shortness of breath (50 [58.8%]), fatigue (50 [58.8%]), dyspnea (60 [70.6%]). Hypertension, diabetes and coronary heart disease were the most common comorbidities. Notably, 81.2% patients had very low eosinophil counts at admission. Complications included respiratory failure (80 [94.1%]), shock (69 [81.2%]), ARDS (63 [74.1%]), arrhythmia (51 [60%]), etc. Most patients received antibiotic (77 [90.6%]), antiviral (78 [91.8%]) and glucocorticoids (65 [76.5%]) treatments. 38 patients [44.7%] and 33 [38.8%] received intravenous immunoglobulin and interferon alpha2b respectively. CONCLUSIONS: In this depictive study of 85 fatal cases of COVID-19, most cases were male aged over 50 years old with noncommunicable chronic diseases. The majority of the patients died of multiple organ failure. Early onset of shortness of breath may be used as an observational symptom for COVID-19 exacerbations. Eosinophilopenia may indicate a poor prognosis. The combination of anti-microbial drugs did not offer considerable benefit to the outcome of this group of patients. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/)."],"journal":"Am J Respir Crit Care Med","authors":["Du, Yingzhen","Tu, Lei","Zhu, Pingjun","Mu, Mi","Wang, Runsheng","Yang, Pengcheng","Wang, Xi","Hu, Chao","Ping, Rongyu","Hu, Peng","Li, Tianzhi","Cao, Feng","Chang, Christopher","Hu, Qinyong","Jin, Yang","Xu, Guogang"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32242738","week":"202014|Mar 30 - Apr 05","doi":"10.1164/rccm.202003-0543OC","keywords":["COVID-19","SARS-CoV-2","co-pathogen","eosinophilopenia","fatal cases"],"source":"PubMed","locations":["Eosinophilopenia","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1663352135802159106,"score":120.68104},{"pmid":32304772,"title":"Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China.","text":["Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China.","BACKGROUND: The novel coronavirus disease 2019 (COVID-19) has become a global health emergency. Cumulative number of new confirmed case and death are still increasing out of China. However, the independent predicted factors associated with the fatal outcome remain uncertain. METHODS: A retrospective cohort of 1590 hospitalized subjects with COVID-19 throughout China was established. The prognostic effects of variables, including clinical features and laboratory findings, were analyzed using Kapla-Meier method and Cox proportional hazard model. A prognostic nomogram was formulated to predict the survival of patient with COVID-19. RESULTS: In this nationwide cohort, non-survivors showed higher incidence of elderly people, subjects with co-existing chronic illness, dyspnea and laboratory abnormalities on admission, compared with survivors. Multivariate Cox regression analysis showed that age>/=75 (HR: 7.86, 95% CI: 2.44-25.35), age between 65-74 years (HR:3.43, 95%CI: 1.24-9.5), coronary heart disease (HR:4.28, 95%CI:1.14-16.13), cerebrovascular disease(HR:3.1, 95%CI:1.07-8.94), dyspnea (HR: 3.96, 95%CI:1.42-11), procalcitonin>0.5ng/ml(HR:8.72, 95%CI:3.42-22.28), aspartate aminotransferase>40U/liter (HR: 2.2, 95% CI: 1.1- 6.73) were independent risk factors associated with fatal outcome. A nomogram was established based on the results of multivariate analysis. The internal bootstrap resampling approach suggested the nomogram has sufficient discriminatory power with the C-index of 0.91 (95%CI 0.85-0.97). The calibration plots also demonstrated good consistence between the prediction and the observation. CONCLUSIONS: The proposed nomogram accurately predict clinical outcomes of patients with COVID-19 based on individual characteristics. Earlier identification, more intensive surveillance and appropriate therapy should be considered in patients with high risk.","Chest","Chen, Ruchong","Liang, Wenhua","Jiang, Mei","Guan, Weijie","Zhan, Chen","Wang, Tao","Tang, Chunli","Sang, Ling","Liu, Jiaxing","Ni, Zhengyi","Hu, Yu","Liu, Lei","Shan, Hong","Lei, Chunliang","Peng, Yixiang","Wei, Li","Liu, Yong","Hu, Yahua","Peng, Peng","Wang, Jianming","Liu, Jiyang","Chen, Zhong","Li, Gang","Zheng, Zhijian","Qiu, Shaoqin","Luo, Jie","Ye, Changjiang","Zhu, Shaoyong","Liu, Xiaoqing","Cheng, Linling","Ye, Feng","Zheng, Jinping","Zhang, Nuofu","Li, Yimin","He, Jianxing","Li, Shiyue","Zhong, Nanshan","32304772"],"abstract":["BACKGROUND: The novel coronavirus disease 2019 (COVID-19) has become a global health emergency. Cumulative number of new confirmed case and death are still increasing out of China. However, the independent predicted factors associated with the fatal outcome remain uncertain. METHODS: A retrospective cohort of 1590 hospitalized subjects with COVID-19 throughout China was established. The prognostic effects of variables, including clinical features and laboratory findings, were analyzed using Kapla-Meier method and Cox proportional hazard model. A prognostic nomogram was formulated to predict the survival of patient with COVID-19. RESULTS: In this nationwide cohort, non-survivors showed higher incidence of elderly people, subjects with co-existing chronic illness, dyspnea and laboratory abnormalities on admission, compared with survivors. Multivariate Cox regression analysis showed that age>/=75 (HR: 7.86, 95% CI: 2.44-25.35), age between 65-74 years (HR:3.43, 95%CI: 1.24-9.5), coronary heart disease (HR:4.28, 95%CI:1.14-16.13), cerebrovascular disease(HR:3.1, 95%CI:1.07-8.94), dyspnea (HR: 3.96, 95%CI:1.42-11), procalcitonin>0.5ng/ml(HR:8.72, 95%CI:3.42-22.28), aspartate aminotransferase>40U/liter (HR: 2.2, 95% CI: 1.1- 6.73) were independent risk factors associated with fatal outcome. A nomogram was established based on the results of multivariate analysis. The internal bootstrap resampling approach suggested the nomogram has sufficient discriminatory power with the C-index of 0.91 (95%CI 0.85-0.97). The calibration plots also demonstrated good consistence between the prediction and the observation. CONCLUSIONS: The proposed nomogram accurately predict clinical outcomes of patients with COVID-19 based on individual characteristics. Earlier identification, more intensive surveillance and appropriate therapy should be considered in patients with high risk."],"journal":"Chest","authors":["Chen, Ruchong","Liang, Wenhua","Jiang, Mei","Guan, Weijie","Zhan, Chen","Wang, Tao","Tang, Chunli","Sang, Ling","Liu, Jiaxing","Ni, Zhengyi","Hu, Yu","Liu, Lei","Shan, Hong","Lei, Chunliang","Peng, Yixiang","Wei, Li","Liu, Yong","Hu, Yahua","Peng, Peng","Wang, Jianming","Liu, Jiyang","Chen, Zhong","Li, Gang","Zheng, Zhijian","Qiu, Shaoqin","Luo, Jie","Ye, Changjiang","Zhu, Shaoyong","Liu, Xiaoqing","Cheng, Linling","Ye, Feng","Zheng, Jinping","Zhang, Nuofu","Li, Yimin","He, Jianxing","Li, Shiyue","Zhong, Nanshan"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32304772","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.chest.2020.04.010","keywords":["covid-19","fatal outcome","nomogram","risk factors"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"locations":["China","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664431720523366400,"score":119.59394},{"pmid":32301761,"title":"Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes.","text":["Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes.","OBJECTIVES: Coronavirus disease 2019 (COVID-19) most commonly presents with respiratory symptoms, including cough, shortness of breath, and sore throat. However, digestive symptoms also occur in patients with COVID-19 and are often described in outpatients with less severe disease. In this study, we sought to describe the clinical characteristics of COVID-19 patients with digestive symptoms and mild disease severity. METHODS: We identified COVID-19 patients with mild disease and one or more digestive symptoms (diarrhea, nausea, and vomiting), with or without respiratory symptoms, and compared them with a group presenting solely with respiratory symptoms. We followed up patients clinically until they tested negative for COVID-19 on at least 2 sequential respiratory tract specimens collected >/=24 hours apart. We then compared the clinical features between those with digestive symptoms and those with respiratory symptoms. RESULTS: There were 206 patients with low severity COVID-19, including 48 presenting with a digestive symptom alone, 69 with both digestive and respiratory symptoms, and 89 with respiratory symptoms alone. Between the 2 groups with digestive symptoms, 67 presented with diarrhea, of whom 19.4% experienced diarrhea as the first symptom in their illness course. The diarrhea lasted from 1 to 14 days, with an average duration of 5.4 +/- 3.1 days and a frequency of 4.3 +/- 2.2 bowel movements per day. Concurrent fever was found in 62.4% of patients with a digestive symptom. Patients with digestive symptoms presented for care later than those with respiratory symptoms (16.0 +/- 7.7 vs 11.6 +/- 5.1 days, P < 0.001). Nevertheless, patients with digestive symptoms had a longer duration between symptom onset and viral clearance (P < 0.001) and were more likely to be fecal virus positive (73.3% vs 14.3%, P = 0.033) than those with respiratory symptoms. DISCUSSION: We describe a unique subgroup of COVID-19 patients with mild disease severity marked by the presence of digestive symptoms. These patients are more likely to test positive for viral RNA in stool, to have a longer delay before viral clearance, and to experience delayed diagnosis compared with patients with only respiratory symptoms.","Am J Gastroenterol","Han, Chaoqun","Duan, Caihan","Zhang, Shengyan","Spiegel, Brennan","Shi, Huiying","Wang, Weijun","Zhang, Lei","Lin, Rong","Liu, Jun","Ding, Zhen","Hou, Xiaohua","32301761"],"abstract":["OBJECTIVES: Coronavirus disease 2019 (COVID-19) most commonly presents with respiratory symptoms, including cough, shortness of breath, and sore throat. However, digestive symptoms also occur in patients with COVID-19 and are often described in outpatients with less severe disease. In this study, we sought to describe the clinical characteristics of COVID-19 patients with digestive symptoms and mild disease severity. METHODS: We identified COVID-19 patients with mild disease and one or more digestive symptoms (diarrhea, nausea, and vomiting), with or without respiratory symptoms, and compared them with a group presenting solely with respiratory symptoms. We followed up patients clinically until they tested negative for COVID-19 on at least 2 sequential respiratory tract specimens collected >/=24 hours apart. We then compared the clinical features between those with digestive symptoms and those with respiratory symptoms. RESULTS: There were 206 patients with low severity COVID-19, including 48 presenting with a digestive symptom alone, 69 with both digestive and respiratory symptoms, and 89 with respiratory symptoms alone. Between the 2 groups with digestive symptoms, 67 presented with diarrhea, of whom 19.4% experienced diarrhea as the first symptom in their illness course. The diarrhea lasted from 1 to 14 days, with an average duration of 5.4 +/- 3.1 days and a frequency of 4.3 +/- 2.2 bowel movements per day. Concurrent fever was found in 62.4% of patients with a digestive symptom. Patients with digestive symptoms presented for care later than those with respiratory symptoms (16.0 +/- 7.7 vs 11.6 +/- 5.1 days, P < 0.001). Nevertheless, patients with digestive symptoms had a longer duration between symptom onset and viral clearance (P < 0.001) and were more likely to be fecal virus positive (73.3% vs 14.3%, P = 0.033) than those with respiratory symptoms. DISCUSSION: We describe a unique subgroup of COVID-19 patients with mild disease severity marked by the presence of digestive symptoms. These patients are more likely to test positive for viral RNA in stool, to have a longer delay before viral clearance, and to experience delayed diagnosis compared with patients with only respiratory symptoms."],"journal":"Am J Gastroenterol","authors":["Han, Chaoqun","Duan, Caihan","Zhang, Shengyan","Spiegel, Brennan","Shi, Huiying","Wang, Weijun","Zhang, Lei","Lin, Rong","Liu, Jun","Ding, Zhen","Hou, Xiaohua"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32301761","week":"202016|Apr 13 - Apr 19","doi":"10.14309/ajg.0000000000000664","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664357978638123008,"score":119.51356},{"pmid":32276095,"title":"Symptom Cluster of ICU nurses treating COVID-19 pneumonia patients in Wuhan, China.","text":["Symptom Cluster of ICU nurses treating COVID-19 pneumonia patients in Wuhan, China.","OBJECTIVE: In treating highly infectious COVID-19 pneumonia, ICU nurses face a high risk of developing somatic symptom disorder (SSD). The present study aims to investigate the symptoms and causes of SSD of ICU nurses treating COVID-19 pneumonia. The research results are expected to provide evidence for the establishment of a better management strategy. METHODS: This study enrolled a total of 140 ICU nurses who were selected by Jiangsu Province Hospital to work in Wuhan (the epicenter of the COVID-19 epidemic in China) on 3(rd) February 2020. A questionnaire \"Somatic Symptom Disorders for ICU Nurses in Wuhan No.1 Hospital\" was designed based on the \"International Classification of Functioning, Disability and Health\" (ICF). Exploratory factor analysis was performed to cluster the symptoms, and logistic regression analysis to find the risk factors of the symptoms. RESULTS: Five major symptoms were chest-discomfort-and-palpitation (31.4%), dyspnea (30.7%), nausea (21.4%), headache (19.3%), and dizziness (17.9%). In exploratory factor analysis, the symptoms were classified into three clusters: Cluster A of breathing and sleep disturbances (dizziness, sleepiness, dyspnea); Cluster B of gastrointestinal complaints and pain (nausea, headache), and Cluster C of general symptoms (xerostomia, fatigue, chest-discomfort-and-palpitation). In Cluster A, urine/feces splash, sex, and sputum splash were independent predictive factors. In Cluster B, fall of protective glasses and urine/feces splash were independent predictive factors. In Cluster C, urine/feces splash and urine/feces clearance were independent predictive factors. CONCLUSION: The ICU nurses in Wuhan showed varying and overlapping SSDs. These SSDs could be classified into three symptom clusters. Based on the characteristics of their SSDs, specific interventions could be implemented to safeguard the health of ICU nurses.","J Pain Symptom Manage","Yifan, Tang","Ying, Liu","Chunhong, Gao","Jing, Song","Rong, Wang","Zhenyu, Li","Zejuan, Gu","Peihung, Liao","32276095"],"abstract":["OBJECTIVE: In treating highly infectious COVID-19 pneumonia, ICU nurses face a high risk of developing somatic symptom disorder (SSD). The present study aims to investigate the symptoms and causes of SSD of ICU nurses treating COVID-19 pneumonia. The research results are expected to provide evidence for the establishment of a better management strategy. METHODS: This study enrolled a total of 140 ICU nurses who were selected by Jiangsu Province Hospital to work in Wuhan (the epicenter of the COVID-19 epidemic in China) on 3(rd) February 2020. A questionnaire \"Somatic Symptom Disorders for ICU Nurses in Wuhan No.1 Hospital\" was designed based on the \"International Classification of Functioning, Disability and Health\" (ICF). Exploratory factor analysis was performed to cluster the symptoms, and logistic regression analysis to find the risk factors of the symptoms. RESULTS: Five major symptoms were chest-discomfort-and-palpitation (31.4%), dyspnea (30.7%), nausea (21.4%), headache (19.3%), and dizziness (17.9%). In exploratory factor analysis, the symptoms were classified into three clusters: Cluster A of breathing and sleep disturbances (dizziness, sleepiness, dyspnea); Cluster B of gastrointestinal complaints and pain (nausea, headache), and Cluster C of general symptoms (xerostomia, fatigue, chest-discomfort-and-palpitation). In Cluster A, urine/feces splash, sex, and sputum splash were independent predictive factors. In Cluster B, fall of protective glasses and urine/feces splash were independent predictive factors. In Cluster C, urine/feces splash and urine/feces clearance were independent predictive factors. CONCLUSION: The ICU nurses in Wuhan showed varying and overlapping SSDs. These SSDs could be classified into three symptom clusters. Based on the characteristics of their SSDs, specific interventions could be implemented to safeguard the health of ICU nurses."],"journal":"J Pain Symptom Manage","authors":["Yifan, Tang","Ying, Liu","Chunhong, Gao","Jing, Song","Rong, Wang","Zhenyu, Li","Zejuan, Gu","Peihung, Liao"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32276095","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.jpainsymman.2020.03.039","keywords":["COVID-19","Intensive Care Units","Occupational exposure","Symptom Cluster","Symptoms"],"source":"PubMed","locations":["Wuhan","China","Wuhan","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1663712077931347968,"score":113.90898}]}